NCT00096083View on ClinicalTrials.gov

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Cancer
Interventions
DRUG

isolated perfusion

DRUG

melphalan

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Delcath Systems Inc.

INDUSTRY

NCT00096083 - Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer | Biotech Hunter | Biotech Hunter